These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26201792)

  • 1. The Fatty Liver Index has limited utility for the detection and quantification of hepatic steatosis in obese patients.
    Borman MA; Ladak F; Crotty P; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Duarte-Rojo A; Elkashab M; Myers RP
    Hepatol Int; 2013 Jun; 7(2):592-9. PubMed ID: 26201792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.
    Carvalhana S; Leitão J; Alves AC; Bourbon M; Cortez-Pinto H
    Liver Int; 2014 Jul; 34(6):e111-7. PubMed ID: 24034415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
    Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.
    Zelber-Sagi S; Webb M; Assy N; Blendis L; Yeshua H; Leshno M; Ratziu V; Halpern Z; Oren R; Santo E
    World J Gastroenterol; 2013 Jan; 19(1):57-64. PubMed ID: 23326163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fatty liver index is associated with increased mortality in subjects referred to coronary angiography.
    Lerchbaum E; Pilz S; Grammer TB; Boehm BO; Stojakovic T; Obermayer-Pietsch B; März W
    Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1231-8. PubMed ID: 23557879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes.
    Sviklāne L; Olmane E; Dzērve Z; Kupčs K; Pīrāgs V; Sokolovska J
    J Gastroenterol Hepatol; 2018 Jan; 33(1):270-276. PubMed ID: 28464337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
    Chan WK; Nik Mustapha NR; Mahadeva S
    J Gastroenterol Hepatol; 2014; 29(7):1470-6. PubMed ID: 24548002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome.
    Chen LD; Huang JF; Chen QS; Lin GF; Zeng HX; Lin XF; Lin XJ; Lin L; Lin QC
    Chin Med J (Engl); 2019 Nov; 132(22):2670-2676. PubMed ID: 31765354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases.
    Ballestri S; Nascimbeni F; Baldelli E; Marrazzo A; Romagnoli D; Targher G; Lonardo A
    Metabolism; 2017 Jul; 72():57-65. PubMed ID: 28641784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease.
    Kim HN; Jeon HJ; Choi HG; Kwon IS; Rou WS; Lee JE; Lee TH; Kim SH; Lee BS; Shin KS; Lee HJ; Eun HS
    BMC Gastroenterol; 2023 Mar; 23(1):77. PubMed ID: 36932382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction and validation of nonalcoholic fatty liver disease by fatty liver index in a Japanese population.
    Takahashi S; Tanaka M; Higashiura Y; Mori K; Hanawa N; Ohnishi H; Furuhashi M
    Endocr J; 2022 Apr; 69(4):463-471. PubMed ID: 34803123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A community-based study on the application of fatty liver index in screening subjects with nonalcoholic fatty liver disease.
    Chen LW; Huang PR; Chien CH; Lin CL; Chien RN
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):173-181. PubMed ID: 30981560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty liver index in polycystic ovary syndrome.
    Lerchbaum E; Gruber HJ; Schwetz V; Giuliani A; Möller R; Pieber TR; Obermayer-Pietsch B
    Eur J Endocrinol; 2011 Dec; 165(6):935-43. PubMed ID: 21937505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-specific cut-off points of fatty liver index: a study based on the National Health and Nutrition Examination Survey data.
    Wu J; Tian S; Li H; Xu Z; Li S; Chen YL; Liang XY; Xiao J; Song JY; She RL; Ma CY; Feng JH; Li ZX; Jiang ZY; Zhang ZW; Wu KN; Kong LQ
    BMC Gastroenterol; 2022 May; 22(1):265. PubMed ID: 35624410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population.
    Bedogni G; Bellentani S; Miglioli L; Masutti F; Passalacqua M; Castiglione A; Tiribelli C
    BMC Gastroenterol; 2006 Nov; 6():33. PubMed ID: 17081293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study.
    Koehler EM; Schouten JN; Hansen BE; Hofman A; Stricker BH; Janssen HL
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1201-4. PubMed ID: 23353640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals.
    Cuthbertson DJ; Weickert MO; Lythgoe D; Sprung VS; Dobson R; Shoajee-Moradie F; Umpleby M; Pfeiffer AF; Thomas EL; Bell JD; Jones H; Kemp GJ
    Eur J Endocrinol; 2014 Nov; 171(5):561-9. PubMed ID: 25298375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees.
    Murayama K; Okada M; Tanaka K; Inadomi C; Yoshioka W; Kubotsu Y; Yada T; Isoda H; Kuwashiro T; Oeda S; Akiyama T; Oza N; Hyogo H; Ono M; Kawaguchi T; Torimura T; Anzai K; Eguchi Y; Takahashi H
    Diagnostics (Basel); 2021 Jan; 11(1):. PubMed ID: 33467114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
    de Lédinghen V; Vergniol J; Foucher J; Merrouche W; le Bail B
    Liver Int; 2012 Jul; 32(6):911-8. PubMed ID: 22672642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.